Related: Diabetes vaccine shows promise for some patients in early trial However, compounded drugs are not FDA-approved, and the FDA does not verify their safety and effectiveness as it does for normal drugs
Further Increase: If additional glycemic control is needed after at least 4 weeks on 0.5 mg, increase to 1 mg once weekly
Study Design SURMOUNT-5 was a randomized, open-label, phase 3b trial conducted over 72 weeks across 32 centers in the United States and Puerto Rico
Well break down whats included in the program, how it compares to other GLP-1 options, and whether its the right fit for your health goals
Lu, F., Gao, J., Ogawa, R., Hyakusoku, H